Short Interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Grows By 24.4%

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) was the target of a large growth in short interest in February. As of February 13th, there was short interest totaling 50,180 shares, a growth of 24.4% from the January 29th total of 40,324 shares. Based on an average daily trading volume, of 15,685 shares, the short-interest ratio is currently 3.2 days. Currently, 0.2% of the shares of the stock are short sold. Currently, 0.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 15,685 shares, the short-interest ratio is currently 3.2 days.

Hedge Funds Weigh In On Oaktree Acquisition Corp. III Life Sciences

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Clear Street Group Inc. purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 3rd quarter worth $231,000. Clear Street LLC increased its position in Oaktree Acquisition Corp. III Life Sciences by 265.1% during the 2nd quarter. Clear Street LLC now owns 22,000 shares of the company’s stock valued at $230,000 after buying an additional 15,975 shares in the last quarter. Readystate Asset Management LP purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the third quarter worth about $262,000. Meteora Capital LLC acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the second quarter valued at about $517,000. Finally, Radcliffe Capital Management L.P. purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 2nd quarter valued at approximately $856,000.

Oaktree Acquisition Corp. III Life Sciences Price Performance

Oaktree Acquisition Corp. III Life Sciences stock remained flat at $10.70 during midday trading on Tuesday. 108,855 shares of the company were exchanged, compared to its average volume of 13,285. The stock has a 50-day simple moving average of $10.63 and a two-hundred day simple moving average of $10.57. Oaktree Acquisition Corp. III Life Sciences has a 12 month low of $10.03 and a 12 month high of $10.85.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.